Clinical Trial Update: ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ISIS 5132 in patients with metastatic or recurrent ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• ISIS 5132

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED